Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated With Different Outcomes Among Patients With Venous Thromboembolism?
Spyropoulos, Alex C., Preblick, Ron, Kwong, Winghan J., Lingohr-Smith, Melissa, Lin, Jay
Published in Clinical and applied thrombosis/hemostasis (01.09.2017)
Published in Clinical and applied thrombosis/hemostasis (01.09.2017)
Get full text
Journal Article
Abstract 13528: Sex Differences in Healthcare Resource Utilization in Patients With Atrial Fibrillation Receiving Dronedarone versus Sotalol Following Ablation
Zeitler, Emily P, Stein, Dara, PREBLICK, RON, Kabadi, Shaum, MCKINDLEY, David, Rashkin, Jason, Huse, Samuel, Stamas, Nicole, Kim, Michael H
Published in Circulation (New York, N.Y.) (08.11.2022)
Published in Circulation (New York, N.Y.) (08.11.2022)
Get full text
Journal Article
Abstract 13500: Real-World Healthcare Resource Utilization Outcomes With Dronedarone versus Sotalol Following Ablation in Adults With Atrial Fibrillation
Zeitler, Emily P, Stein, Dara, PREBLICK, RON, Kabadi, Shaum M, MCKINDLEY, David, Rashkin, Jason, Huse, Samuel, Stamas, Nicole, Kim, Michael H
Published in Circulation (New York, N.Y.) (08.11.2022)
Published in Circulation (New York, N.Y.) (08.11.2022)
Get full text
Journal Article
Abstract 15002: Real-World Healthcare Resource Utilization Among US Patients With Atrial Fibrillation Receiving Dronedarone versus Ablation as 1st-Line Therapy
Greene, Stephen J, Schilsky, Samantha, Roberts, Andrew W, Kabadi, Shaum M, MCKINDLEY, David, PREBLICK, RON, Rashkin, Jason, Leeming, Reno, Sajedian, Renee, Russo, Andrea M
Published in Circulation (New York, N.Y.) (08.11.2022)
Published in Circulation (New York, N.Y.) (08.11.2022)
Get full text
Journal Article
812-P: Real-World Persistence, Adherence, Health Care Resource Utilization (HRU), and Hypoglycemia in People with Type 2 Diabetes (T2D) Continuing the 2nd-Generation (2nd-Gen) Basal Insulin (BI) (Glargine 300 U/mL [Gla-300]) vs. Switching to a 1st-Generation (1st-Gen) BI (Glargine 100 U/mL [Gla-100] or Detemir [IDet 100 U/mL])
EDELMAN, STEVEN, GOLDMAN, JENNIFER D., MALONE, DANIEL C., PREBLICK, RON, MUNAGA, KOVIDA, LI, XUAN, GILL, JASVINDER, GANGI, SUMANA
Published in Diabetes (New York, N.Y.) (01.06.2022)
Published in Diabetes (New York, N.Y.) (01.06.2022)
Get full text
Journal Article
Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin
Wright, Eugene E, Malone, Daniel C, Trujillo, Jennifer M, Gill, Jasvinder, Huse, Samuel, Li, Xuan, Zhou, Fang Liz, Preblick, Ron, Reid, Timothy
Published in Journal of managed care & specialty pharmacy (01.06.2022)
Published in Journal of managed care & specialty pharmacy (01.06.2022)
Get full text
Journal Article
Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin
Wright, Jr, Eugene E, Malone, Daniel C, Trujillo, Jennifer M, Gill, Jasvinder, Huse, Samuel, Li, Xuan, Zhou, Fang Liz, Preblick, Ron, Reid, Timothy
Published in Journal of managed care & specialty pharmacy (01.06.2022)
Get more information
Published in Journal of managed care & specialty pharmacy (01.06.2022)
Journal Article
Cost-Effectiveness Analysis of rFVIIIFc Versus Contemporary rFVIII Treatments for Patients with Severe Hemophilia A Without Inhibitors in the United States
Bullement, Ash, Knowles, Emma S., DasMahapatra, Pronabesh, Ali, Talaha, Preblick, Ron
Published in PharmacoEconomics - open (01.12.2021)
Published in PharmacoEconomics - open (01.12.2021)
Get full text
Journal Article
Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching from Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D
SULLIVAN, SEAN D., BAILEY, TIMOTHY S., ROUSSEL, RONAN, ZHOU, FANG L., BOSNYAK, ZSOLT, PREBLICK, RON, WESTERBACKA, JUKKA, GUPTA, RISHAB, BLONDE, LAWRENCE
Published in Diabetes (New York, N.Y.) (01.07.2018)
Published in Diabetes (New York, N.Y.) (01.07.2018)
Get full text
Journal Article
Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+ Subgroup Analyses
SULLIVAN, SEAN D., BAILEY, TIMOTHY S., ROUSSEL, RONAN, ZHOU, FANG L., BOSNYAK, ZSOLT, PREBLICK, RON, WESTERBACKA, JUKKA, GUPTA, RISHAB, BLONDE, LAWRENCE
Published in Diabetes (New York, N.Y.) (01.07.2018)
Published in Diabetes (New York, N.Y.) (01.07.2018)
Get full text
Journal Article
Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated with Different Outcomes Among Patients with Venous Thromboembolism?
Spyropoulos, Alex C., Preblick, Ron, Kwong, Jackie, Lingohr-Smith, Melissa, Lin, Jay
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
168-LB: Burden of Cardiovascular Comorbidity in U.S. Adults with T1D
EDELMAN, STEVEN V., ZHOU, FANG L., PREBLICK, RON, VERMA, SUMIT, PARANJAPE, SACHIN A., DAVIES, MICHAEL J., JOISH, VIJAY N.
Published in Diabetes (New York, N.Y.) (01.06.2019)
Published in Diabetes (New York, N.Y.) (01.06.2019)
Get full text
Journal Article
Abstract 124: The Effect of Renal Impairment on The Venous Thromboembolism Recurrence and Major Bleeding Risk and Total Health Care Costs in Patients With Acute Venous Thromboembolism
Cai, Jennifer, Kwong, Jackie, Preblick, Ron, Zhang, Qiaoyi
Published in Circulation Cardiovascular quality and outcomes (01.05.2015)
Published in Circulation Cardiovascular quality and outcomes (01.05.2015)
Get full text
Journal Article